怀孕期间的口服葡萄糖耐受性测试可以作为未来糖尿病的宝贵预测指标
Tal Schiller1, Linoy Gabay2, Oren Barak3
1Institute of Endocrinology, Diabetes and Metabolic Disease, Wolfson Medical Center, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
The Journal of clinical endocrinology and metabolism
|September 26, 2025
概括
妊娠糖尿病查结果预测了未来的2型糖尿病 (T2D) 风险. 异常的口服葡萄糖耐受性测试 (OGTT) 值,特别是禁食葡萄糖,显著增加T2D的可能性,告知有针对性的预防策略.
科学领域:
- 内分泌学 在内分泌学.
- 生殖健康 生殖健康
- 糖尿病研究 糖尿病研究
背景情况:
- 在妊娠糖尿病 (GDM) 诊断后对分娩后查的遵守率较低.
- 孕期糖尿病 (GDM) 是未来2型糖尿病 (T2D) 的重要危险因素.
研究的目的:
- 评估怀孕期间异常口服葡萄糖耐受性测试 (OGTT) 结果与随后患2型糖尿病 (T2D) 的风险之间的关联.
- 为了确定最强烈地预测T2D发育后怀孕的特定OGTT参数.
主要方法:
- 一项追溯性队列研究,对107,889名年龄在20-50岁的女性进行,没有先前的T2D,使用来自以色列主要医疗保健提供者的数据 (2000-2022).
- 在怀孕期间分析100克的OGTT结果和T2D发展到2024年9月.
- 考克斯的比例危险模型被用来根据异常OGTT值的数量和类型来评估T2D风险.
主要成果:
- 总共有4,500名 (0.5%) 妇女在6.7年的中位数随访期间发展出T2D.
- 增加T2D风险与异常OGTT值的数量相关:HR为3.45一个,4.03两个,7.15三个,10.60四个异常值.
- 异常的禁食葡萄糖 (HR 5.28) 与异常的非禁食值 (HR 3.03) 相比,具有更高的T2D风险. 之前的GDM诊断仍然是一个风险因素,即使目前的OGTT结果正常.
结论:
- 怀孕期间异常OGTT结果的数量和性质是未来T2D的强有力的预测因素.
- 这些发现支持开发预测工具和针对性产后干预措施,以预防高风险女性早期T2D.
- 早期识别GDM后T2D风险对于有效的管理和预防策略至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
585
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
585
Hypoglycemia and Glucagon
835
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
835
Glucose Transporters
27.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K


